Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer.

about

Time-dependent pharmacokinetics of dexamethasone and its efficacy in human breast cancer xenograft mice: a semi-mechanism-based pharmacokinetic/pharmacodynamic model.Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy

P2860

Q47614448-EFE5B0BC-C571-4CF5-AD92-D852820C73F9 Q57075019-C494965C-0282-4071-9CF7-864858E386EE

P2860

Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer.

Item

http://www.wikidata.org/entity/Q38709654

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Dopamine D2 receptor antagonis ...... and metastatic breast cancer.

@en

type

Item

label

Dopamine D2 receptor antagonis ...... and metastatic breast cancer.

@en

prefLabel

Dopamine D2 receptor antagonis ...... and metastatic breast cancer.

@en

P1476

Dopamine D2 receptor antagonis ...... and metastatic breast cancer.

@en

P2093

Hong Su

http://www.w3.org/2001/XMLSchema#string

Jian Li

http://www.w3.org/2001/XMLSchema#string

Jun-Sheng Xue

http://www.w3.org/2001/XMLSchema#string

Li-Jie Wang

http://www.w3.org/2001/XMLSchema#string

Qing-Yu Yao

http://www.w3.org/2001/XMLSchema#string

Si-Yuan Wang

http://www.w3.org/2001/XMLSchema#string

Tian-Yan Zhou

http://www.w3.org/2001/XMLSchema#string

Wei Lu

http://www.w3.org/2001/XMLSchema#string

Wen-Jun Chen

http://www.w3.org/2001/XMLSchema#string

Xiu-Yun Tian

http://www.w3.org/2001/XMLSchema#string

P2860

Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy

The epithelial-mesenchymal transition generates cells with properties of stem cells

New directions for drug-resistant breast cancer: the CDK4/6 inhibitors

Application of metabolomics in drug resistant breast cancer research

Cancer statistics, 2015

Epithelial-mesenchymal transitions in development and disease

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

Matrix metalloproteinases: regulators of the tumor microenvironment

Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells.

N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties.

P2888

aps.2017.24

P304

1282-1296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2017.24

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1086222794

http://www.w3.org/2001/XMLSchema#string

P698

28649130

http://www.w3.org/2001/XMLSchema#string

P921

dopamine

dexamethasone

P932

5589964

http://www.w3.org/2001/XMLSchema#string

Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer.

about

P2860

P2860

Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932